A Satellite Symposium during AAAAI 2022 Annual Meeting
This event will be presented in-person and virtually by simulcast.
Saturday, February 26, 2022
Reception and Registration
8:30 PM – 8:45 PM MST
Symposium and Panel Discussions
8:45 PM – 10:15 PM MST
Sheraton Phoenix Downtown
Phoenix Ballroom C, Third Level
340 North Third Street
Phoenix, AZ 85004
Either in-person or virtually by simulcast, please join our multidisciplinary expert panel plus an experienced patient with EoE as they discuss this challenging chronic disease. The panel will address diagnosis and management, as well as pathophysiologic pathways and targets that are currently being explored for its treatment.
Eosinophilic esophagitis (EoE) is a rare, debilitating chronic inflammatory disorder. Unfortunately, diagnostic delay is common and current management approaches do not fully address EoE symptoms or provide endoscopic and histologic resolution. However, several pathophysiologic pathways have been described and targeted therapies are under study for the treatment of EoE.
FACULTY
Matthew Greenhawt, MD, MBA, MSc (Chair)
Professor, Pediatrics
Director, Food Challenge and Research Unit
Section of Allergy and Immunology
Children's Hospital Colorado
University of Colorado School of Medicine
Aurora, CO
Seema S. Aceves, MD, PhD
Professor, Pediatrics and Medicine
MRD Endowed Chair, Pediatrics
Director, Eosinophilic Gastrointestinal Disorders Clinic
Division of Allergy Immunology
Rady Children's Hospital San Diego
University of California, San Diego
La Jolla, CA
Evan S. Dellon, MD, MPH
Professor, Medicine
Adjunct Professor, Epidemiology
University of North Carolina School of Medicine
Chapel Hill, NC
PROGRAM AGENDA
Matthew Greenhawt, MD, MBA, MSc
Evan S. Dellon, MD, MPH and Panel including Experienced Patient
Potential Benefits and Limitations
Matthew Greenhawt, MD, MBA, MSc and Panel including Experienced Patient
What are the Implications for Future Treatment?
Seema S. Aceves, MD, PhD and Panel including Experienced Patient
All faculty
WHO SHOULD ATTEND?
This activity is intended for allergy/immunology physicians, NPs, and PAs who manage patients with EoE.
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this activity, participants should be better able to:
- Identify patients with eosinophilic esophagitis (EoE) early by applying guideline-based diagnostic approaches
- Assess the potential benefits and disadvantages of contemporary management strategies for patients with EoE
- Summarize the role of type 2-mediated immune reactivity in the development of EoE and its implication for treatment
- Analyze available data on therapies targeting type 2 immune reactivity for the treatment of patients with EoE
PROVIDER STATEMENT
This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
Americans WIth Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at contact@rmei.com.
FEE INFORMATION
There is no fee for this educational activity.
This program is not sponsored or programmed by the AAAAI.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.